<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WH0F7BLJ</identifier><date>2004</date><creator>Modic, Mojca</creator><creator>Sever, Matjaž</creator><relation>documents/doc/W/URN_NBN_SI_doc-WH0F7BLJ_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WH0F7BLJ_001.txt</relation><format format_type="type">article</format><format format_type="extent">str. I-27-I-30</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">17679065</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WH0F7BLJ</identifier><language>slv</language><publisher publisher_location="[Ljubljana]">Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Adverse Effects</subject><subject language_type_id="slv">Citogenetika</subject><subject language_type_id="slv">Cytogenetics</subject><subject language_type_id="slv">Drug Therapy</subject><subject language_type_id="slv">Hematologic Tests</subject><subject language_type_id="slv">Hematološki testi</subject><subject language_type_id="slv">Leukemia, Myeloid, Chronic</subject><subject language_type_id="slv">Levkemija mieloidna, kronična</subject><subject language_type_id="slv">Mesylates</subject><subject language_type_id="slv">Mezilati</subject><subject language_type_id="slv">Pharmacology</subject><subject language_type_id="slv">Treatment Outcome</subject><subject language_type_id="slv">Zdravljenje, izid</subject><title>Naše izkušnje zdravljenja kronične mieloične levkemije z imatinib mesilatom</title><title>Our experience with treatment of chronic myeloid leukemia with imatinib mesylate</title></Record>